An OpenAI campaign for a pharmaceutical company is optimised by monitoring progress, analysing the data and adjusting investment, creative and strategy over time. A campaign that has been launched is not a finished campaign: the best-performing messages guide the new variants. Each new variant follows the same clarity criteria and the same copy review process your company has in place.
Shared reports
We discuss the performance reports with you and decide together the priorities for the next stages. Find out more about our ChatGPT Ads campaigns service.

Do you already have a campaign to improve?
Tell us how it is set up: we will assess together how to optimise it and prepare a tailored quote.
The cost of a ChatGPT Ads campaign for a pharmaceutical company depends on goals, advertising investment, the number of products or areas to promote, ad variants, pages to prepare and ongoing management. NewVisibility prepares a tailored quote after discussing your goals.
A ChatGPT Ads agency between Como and Lugano such as NewVisibility, based in Cantù, works with companies in Como, Brianza, Milan, Lugano and Canton Ticino, coordinating campaigns, website and content. For a pharmaceutical company, it means a single point of contact for well-organised, trustworthy communication.
ChatGPT Ads campaigns for pharmaceutical companies are ads that bring expertise and products into the context where people look for answers with artificial intelligence. NewVisibility, a marketing agency in Cantù, plans and manages them: strategy, clear ads and optimisation, starting from a discussion of your goals.
Whether ChatGPT advertising is suitable for a pharmaceutical company depends on goals, products, audience and the rules of the sector. NewVisibility starts by discussing your goals and assesses with you whether ChatGPT Ads makes sense; for regulatory aspects, check with your own consultant or regulatory team.
Pharmaceutical advertising on ChatGPT must respect the sector's specific rules on communication. NewVisibility does not provide legal or regulatory advice: we build clear, well-organised messages and include in the process a review of the copy by your consultant or regulatory team before publication.





